MDL 27695

Drug Profile

MDL 27695

Latest Information Update: 14 Jul 1998

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Aventis
  • Class Antimalarials; Antiprotozoals
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Protozoan infections

Most Recent Events

  • 14 Jul 1998 No-Development-Reported for Protozoal infections in USA (Unknown route)
  • 10 Oct 1995 The new ATC/EphMRA codes for MDL 27695 are P01C/P1G.
  • 10 Oct 1995 A new in vivo study has been added to the pharmacodynamics section .
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top